Literature DB >> 10972441

Effects of menstrual phase and smoking abstinence in smokers with and without a history of major depressive disorder.

C S Pomerleau1, A M Mehringer, J L Marks, K K Downey, O F Pomerleau.   

Abstract

Although considerable progress has been made towards understanding the role of menstrual cycle phase in smoking, little is known about the possible effects of menstrual phase upon nicotine intake, withdrawal symptomatology, and craving in women with psychiatric cofactors. Fourteen women with and without a history of Major Depressive Disorder (MDD) were studied during five biologically-confirmed phases over the course of one menstrual cycle: smoking logs, salivary cotinine, and ratings of craving and withdrawal were collected daily. During a second cycle, subjects remained abstinent for 3 consecutive days during the postmenses and premenstrual phases. Although a significant omnibus F-test emerged for cigarettes per day across phases during ad libitum smoking, only trends were observed post hoc and supported midcycle rather than premenstrual elevations. There were no significant phase differences for cotinine. Withdrawal symptomatology was markedly elevated during smoking abstinence and in women with a history of depression. but showed no evidence of phase effects. Thus, the hypothesis that depressed individuals would be differentially affected by phase and abstinence was not strongly supported by our results, though overall elevations emphasize the need for special attention to withdrawal severity in this population. Craving was significantly elevated during smoking abstinence and was significantly higher during postmenses, consistent with the midcycle elevation in smoking rate, but showed no group differences. Our findings overall lend little support for the need to control for menstrual phase under conditions of ad libitum smoking. The strong association of self-reported menstrually related dysphoria during abstinence with both craving and withdrawal symptoms, however, is consistent with an exacerbation of smoking abstinence effects in women with severe menstrual symptomatology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10972441     DOI: 10.1016/s0306-4603(99)00075-1

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  15 in total

1.  Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender.

Authors:  Sarah E Evans; Melissa Blank; Cynthia Sams; Michael F Weaver; Thomas Eissenberg
Journal:  Exp Clin Psychopharmacol       Date:  2006-05       Impact factor: 3.157

2.  Menstrual cycle and cue reactivity in women smokers.

Authors:  Kevin M Gray; Stacia M DeSantis; Matthew J Carpenter; Michael E Saladin; Steven D LaRowe; Himanshu P Upadhyaya
Journal:  Nicotine Tob Res       Date:  2009-12-08       Impact factor: 4.244

3.  Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial.

Authors:  F Joseph McClernon; Elizabeth E Van Voorhees; Joe English; Matt Hallyburton; Alex Holdaway; Scott H Kollins
Journal:  Nicotine Tob Res       Date:  2011-05-12       Impact factor: 4.244

Review 4.  Sex, ADHD symptoms, and smoking outcomes: an integrative model.

Authors:  Elizabeth E Van Voorhees; John T Mitchell; F Joseph McClernon; Jean C Beckham; Scott H Kollins
Journal:  Med Hypotheses       Date:  2012-02-15       Impact factor: 1.538

Review 5.  The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research.

Authors:  Justin J Anker; Marilyn E Carroll
Journal:  Neurosci Biobehav Rev       Date:  2010-04-14       Impact factor: 8.989

Review 6.  Exploring Issues of Comorbid Conditions in People Who Smoke.

Authors:  Alana M Rojewski; Stephen Baldassarri; Nina A Cooperman; Ellen R Gritz; Frank T Leone; Megan E Piper; Benjamin A Toll; Graham W Warren
Journal:  Nicotine Tob Res       Date:  2016-01-17       Impact factor: 4.244

7.  Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion.

Authors:  Carolyn M Mazure; Benjamin Toll; Sherry A McKee; Ran Wu; Stephanie S O'Malley
Journal:  Drug Alcohol Depend       Date:  2010-09-15       Impact factor: 4.492

Review 8.  Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation.

Authors:  Andrea H Weinberger; Philip H Smith; Sharon S Allen; Kelly P Cosgrove; Michael E Saladin; Kevin M Gray; Carolyn M Mazure; Cora Lee Wetherington; Sherry A McKee
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

9.  Smoking processes, panic, and depressive symptoms among treatment-seeking smokers.

Authors:  Dawn W Foster; Kirsten J Langdon; Norman B Schmidt; Michael Zvolensky
Journal:  Subst Use Misuse       Date:  2014-12-15       Impact factor: 2.164

10.  Sex and ovarian hormones influence vulnerability and motivation for nicotine during adolescence in rats.

Authors:  Wendy J Lynch
Journal:  Pharmacol Biochem Behav       Date:  2009-07-18       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.